Tripos International Announces Availability of Topomer CoMFA/Search Product Integration and Topomer Technology Patent Approvals

ST. LOUIS--(BUSINESS WIRE)--Tripos International, leading provider of drug discovery informatics products and services, today announced the availability of integrated versions of its recently patented Topomer Search and Topomer CoMFA® technologies. Tripos’ Topomer technologies accelerate the speed and enhance the accuracy of the process chemists use to predict the biological activity and properties of compounds in chemical discovery and development and enable researchers to search vast numbers of compounds rapidly (1 million compounds overnight).

MORE ON THIS TOPIC